Stock Market Reviews

MYO (Myomo, Inc.) News

Get the latest news, insights, and market updates on MYO (Myomo, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Myomo Reveals its $100 Revenue Goal During Investor Day
  Myomo, Inc. (NYSE:MYO) is one of the 10 Best Small Cap Robotics Stocks to Buy Now. On June 18, the company held an Investor and Analyst Day to assess the company’s business model and long-term aspirations. The company cited its Q1 FY2025 performance and mentioned that its lead generation capabilities helped recover the challenges faced […]
  Jul 10, 2025 - $MYO
• Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last?
  Capricor (CAPR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
  Jun 25, 2025 - $MYO
• Myomo Provides Highlights of Today’s Investor & Analyst Day Event
  BURLINGTON, Mass., June 18, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will host an Investor & Analyst Day event today from 10 a.m. to 3 p.m. Eastern time during which management will provide an in-depth review of the Company’s business model, provide a tour of its new headquarters and manufacturing facility and discuss long-ran
  Jun 18, 2025 - $MYO
• Myomo Inc (MYO) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic Innovations
  Myomo Inc (MYO) reports a 162% revenue increase, driven by the successful launch of MyoPro 2X and strong Medicare Part B penetration, despite advertising challenges.
  May 8, 2025 - $MYO
• Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates
  Myomo (MYO) delivered earnings and revenue surprises of 0% and 6.29%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
  May 7, 2025 - $MYO
• Myomo Reports First Quarter 2025 Financial and Operating Results
  BURLINGTON, Mass., May 07, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2025.
  May 7, 2025 - $MYO
• Myomo to Host Investor & Analyst Day Event on June 18, 2025
  BURLINGTON, Mass., May 01, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the Company will be hosting its first-ever Investor & Analyst Day event on Wednesday, June 18, 2025. The event will take place at Myomo’s new corporate headquarters and manufacturing facility in Burlington, Mass., and will offer an in-depth look at t
  May 1, 2025 - $MYO
• Myomo Launches the MyoPro® 2x
  BURLINGTON, Mass., April 30, 2025--Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers improved arm and hand function for individuals with upper-limb paralysis and neuromuscular conditions, today announced the launch of the MyoPro 2x, the latest evolution in its flagship MyoPro product line.
  Apr 30, 2025 - $MYO
• Myomo to Report First Quarter 2025 Financial Results on May 7
  BURLINGTON, Mass., April 30, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2025 on May 7, 2025.
  Apr 30, 2025 - $MYO
• Myomo Announces Upcoming Changes to its Board of Directors
  BURLINGTON, Mass., April 10, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that directors Amy Knapp and Yitzchak Jacobovitz have informed the board they will not stand for re-election as Class II directors. Ms. Knapp has been a director since July 2016 and Mr. Jacobovitz has served on Myomo’s board since January 202
  Apr 10, 2025 - $MYO